A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants
Clinical trial NCT05015920 · COMPLETED
Trial details
- NCT number
- NCT05015920
- Sponsor
- Shanghai BDgene Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-10
- Primary completion
- 2024-08-23
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.